trial

Psychiatric Genotype/Phenotype Project Repository

NCTId NCT00762866

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Enrolling By Invitation

Enrollment 2,000 (estimated)

Sponsored by Vanderbilt University Medical Center

Primary completion 2027-12

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Enrolling By Invitation

Enrollment

2,000 (estimated)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2008-09

Primary completion

2027-12

Eligibility

ALL · 16 Years · 65 Years

Interventions & indications

Drugs

—

Indications

Bipolar Disorder Psychotic Disorders Depressive Disorder, Major Psychotic Disorders Bipolar Disorder Schizophrenia Depressive Disorder, Major Depression

Investigators

Stephan F Taylor, M.D.Principal Investigator

Sites

1 total

Nashville, United States

Facts & assertions

4 sourced

Enrollment

2,000

Phase

Primary Completion Date

2027-12

Status

ENROLLING_BY_INVITATION

relationships

The graph out of here

lead_sponsor

Vanderbilt University Medical Center

company

indication

Bipolar Disorder

indication

Psychotic Disorders

indication

Depressive Disorder, Major

indication

investigator

Stephan F Taylor, M.D.

person